



Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright 
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
 Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
 You may not further distribute the material or use it for any profit-making activity or commercial gain 
 You may freely distribute the URL identifying the publication in the public portal 
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
  
 
   
 
 
Downloaded from orbit.dtu.dk on: Mar 30, 2019
Building a framework to help define tolerable risk in food allergy
Madsen, Charlotte Bernhard; Baumert, Joseph ; Cavandoli, Elisa; Chan, Chun-Han; Cochrane, Stella;
Houben, Geert; Knibb, Rebecca ; Knulst, André; Ronsmans, Stefan ; Schnadt, Sabine; Turner, Paul; van




Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Madsen, C. B., Baumert, J., Cavandoli, E., Chan, C-H., Cochrane, S., Houben, G., ... Crevel, R. (2018). Building
a framework to help define tolerable risk in food allergy. Poster session presented at science-food-society,
Parma, Italy.
• Food allergy is the daily reality for at least 20 million Europeans 
(more if including their families, colleagues, etc) 
• People with food allergy are a well-defined group who need 
accurate information on food contents to keep themselves safe 
• The law protects them well against exposure to allergenic 
ingredients, but not to unintended allergen presence (UAP) 
• Precautionary allergen labelling (PAL) aims to                                  
mitigate the risk from UAP, however there are no  
     clear rules on whether and when to use PAL 
• There is therefore no general, agreed risk level  
     that triggers use of PAL and people with food  
     allergies are left FRUSTRATED, CONFUSED  
     and are potentially placed AT RISK 
• Healthcare practitioners are UNCLEAR about what advice to give 
about which foods are safe and which aren’t 
• Additionally food businesses face unnecessary UNCERTAINTY 
• Methods now exist which permit the effective derivation of  










• However, they cannot be effectively implemented without a 
decision on what risk is tolerable (can be tolerated/accepted) 
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KEY MESSAGES 
• Unintended allergen presence in foods poses a risk to people with food allergies 
• The rationale and values underlying decisions about what risk is tolerable in food allergy are not clear 
• This lack of clarity has hindered definition of appropriate risk benchmarks for food allergens, leaving people 
with food allergies frustrated and not knowing when to trust that foods are safe for them 
• The ILSI-Europe Food Allergy Task Force has assembled an Expert Group to develop a framework to help 
multiple stakeholders reach consensus on tolerable risk with transparency 
www.ilsi.eu 
• WHO needs to be involved? 
• Decision makers e.g. regulators, food business operators (FBOs) 
• Those bearing the consequences of the decision(s) e.g. people with food 
allergies, care givers, food businesses  
• WHAT must the framework ensure? 
• All relevant factors are considered; data inputs are accurate and accessible 
• Concrete, practicable and theoretically justified information is used and 
conclusions are reached on what types of action to take (or not) 
• Transparent value judgements and methods are applied 
• Description of the societal distribution of the risks 
• HOW should the framework operate? 










• Tolerable risk is the critical link between risk assessment and risk 
management 
• Tolerable risk defines whether risk management objectives are 
attained 
• Defining tolerable risk requires multiple stakeholders to reach valid 
and equitable conclusions, balancing the interests of all 











• Yes, an appropriate, well-matched benchmark is critical 
• Need to reflect that risk only applies to a subpopulation 
Can we compare food 
allergy risk to 
 other accepted food 
related risks? 
•    Difficult to define costs 
• Costs may not increase if PAL is harmonized 
• Cost increases may threaten economic viability for some FBOs 
• If PAL will be regulated then cost of suffering for allergic 
consumers will be reduced: the perception is yes but there is no 
evidence for that… 
Acceptable risk and 
cost versus suffering 
• Different elements of risk assessment have distinct uncertainties:   
• Dose distribution (numbers, frequency and dose in models) 
• Translation from clinical trials (challenge) to community exposures 
• Factors included in the risk assessment models (severity?) 
• Learn by doing: e.g. establish temporary reference doses with one or 
more well-evaluated allergens 
Scientific uncertainty 
and acceptable risk 
• Biases make this approach difficult to use 
• Approach is dependent on knowledge  
• Difficult to factor population versus individual risk 
• How stable is a conclusion over time? 
Is a risk acceptable 
when the general 
public say it is 
acceptable? 
• Lack of consensus among stakeholders 
• Lack of understanding of risk factors/uncertainties 
• Lack of motivation/ no incentive to change 
• Perception of increased risk (compared to current situation) 
What is holding back 
the definition of 
tolerable risk for food 
allergies? 
Understanding the Current Landscape: 
Outcomes from a Workshop Session with Stakeholders on 
Tolerable Risk and Food Allergy  
Kindly provided by Amélie Crepet, Anses 
S.L. Taylor et al. 2009 
Dose distributions (Thresholds) 
